By
Manju T. Beier, PharmD, FASCP
Senior Partner
Geriatric Consultant Resources, LLC
Clinical Associate Professor of Pharmacy
University of Michigan
Ann Arbor, MI
J. Craig Nelson, MD
Leon J. Epstein Professor of Geriatric Psychiatry
Director of Geriatric Psychiatry
University of California, San Francisco
San Francisco, CA
Faculty Disclosure
Manju T. Beier has nothing to disclose.
J. Craig Nelson has nothing to disclose.
Goals and Objectives
At the end of this knowledge-based CPE activity, participants should be able to:
- Recognize barriers to the optimal care of the older patient with depression and anxiety and develop one strategy to address these barriers in your practice.
- Critically analyze current treatments for MDD and GAD in the older patient and assess both their risk and benefit.
- Initiate dialogue that analyzes the benefits of treatment and total costs in your review of treatment costs for depression and anxiety in the older patients.
Target Audience
Pharmacists and other healthcare professionals interested in MDD and GAD.
|
